- call +1-201-465-4211
- email sales@mrinsights.biz
Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of collagen and immune system function. Lack of iron is one of the principal causes of anemia in the general population. It is not surprising that iron deficiency anemia (IDA) is associated with increased morbidity and mortality.
Scope of the Report:
This report focuses on the Intravenous Iron Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Treatment with intravenous iron is clearly superior to oral iron and presents several advantages such as faster and higher increase in Hb levels and replenishment of body iron stores. For these reasons, modern formulations of IV iron have emerged as safe and effective alternatives for IDA management.
The worldwide market for Intravenous Iron Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica
Pharmacosmos
Nippon Shinyaku
NOXXON Pharma
Rockwell Medical
Sanofi
Wanbang Biopharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ferric carboxy maltose
Sucrose
Dextran
Market Segment by Applications, can be divided into
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others
There are 15 Chapters to deeply display the global Intravenous Iron Drugs market.
Chapter 1, to describe Intravenous Iron Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intravenous Iron Drugs, with sales, revenue, and price of Intravenous Iron Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Iron Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intravenous Iron Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intravenous Iron Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Intravenous Iron Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Ferric carboxy maltose
1.2.2 Sucrose
1.2.3 Dextran
1.3 Market Analysis by Applications
1.3.1 Nephrology
1.3.2 Gynecology & Obstetrics
1.3.3 Gastroenterology
1.3.4 Oncology
1.3.5 Cardiology
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Intravenous Iron Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AMAG Pharmaceuticals
2.2.1 Business Overview
2.2.2 Intravenous Iron Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Daiichi Sankyo
2.3.1 Business Overview
2.3.2 Intravenous Iron Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Daiichi Sankyo Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Galenica
2.4.1 Business Overview
2.4.2 Intravenous Iron Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Galenica Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pharmacosmos
2.5.1 Business Overview
2.5.2 Intravenous Iron Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pharmacosmos Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Nippon Shinyaku
2.6.1 Business Overview
2.6.2 Intravenous Iron Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Nippon Shinyaku Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 NOXXON Pharma
2.7.1 Business Overview
2.7.2 Intravenous Iron Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 NOXXON Pharma Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Rockwell Medical
2.8.1 Business Overview
2.8.2 Intravenous Iron Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Rockwell Medical Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Intravenous Iron Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Wanbang Biopharmaceutical
2.10.1 Business Overview
2.10.2 Intravenous Iron Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intravenous Iron Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Intravenous Iron Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous Iron Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intravenous Iron Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Intravenous Iron Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Intravenous Iron Drugs Market Analysis by Regions
4.1 Global Intravenous Iron Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Iron Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intravenous Iron Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
4.5 South America Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
5 North America Intravenous Iron Drugs by Countries
5.1 North America Intravenous Iron Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous Iron Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intravenous Iron Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
6 Europe Intravenous Iron Drugs by Countries
6.1 Europe Intravenous Iron Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous Iron Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intravenous Iron Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
6.3 UK Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
6.4 France Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Intravenous Iron Drugs by Countries
7.1 Asia-Pacific Intravenous Iron Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous Iron Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous Iron Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
7.5 India Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
8 South America Intravenous Iron Drugs by Countries
8.1 South America Intravenous Iron Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Iron Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intravenous Iron Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Intravenous Iron Drugs by Countries
9.1 Middle East and Africa Intravenous Iron Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Iron Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous Iron Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Intravenous Iron Drugs Sales and Growth Rate (2013-2018)
10 Global Intravenous Iron Drugs Market Segment by Type
10.1 Global Intravenous Iron Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous Iron Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous Iron Drugs Revenue and Market Share by Type (2013-2018)
10.2 Ferric carboxy maltose Sales Growth and Price
10.2.1 Global Ferric carboxy maltose Sales Growth (2013-2018)
10.2.2 Global Ferric carboxy maltose Price (2013-2018)
10.3 Sucrose Sales Growth and Price
10.3.1 Global Sucrose Sales Growth (2013-2018)
10.3.2 Global Sucrose Price (2013-2018)
10.4 Dextran Sales Growth and Price
10.4.1 Global Dextran Sales Growth (2013-2018)
10.4.2 Global Dextran Price (2013-2018)
11 Global Intravenous Iron Drugs Market Segment by Application
11.1 Global Intravenous Iron Drugs Sales Market Share by Application (2013-2018)
11.2 Nephrology Sales Growth (2013-2018)
11.3 Gynecology & Obstetrics Sales Growth (2013-2018)
11.4 Gastroenterology Sales Growth (2013-2018)
11.5 Oncology Sales Growth (2013-2018)
11.6 Cardiology Sales Growth (2013-2018)
11.7 Others Sales Growth (2013-2018)
12 Intravenous Iron Drugs Market Forecast (2018-2023)
12.1 Global Intravenous Iron Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous Iron Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous Iron Drugs Market Forecast (2018-2023)
12.2.2 Europe Intravenous Iron Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous Iron Drugs Market Forecast (2018-2023)
12.2.4 South America Intravenous Iron Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous Iron Drugs Market Forecast (2018-2023)
12.3 Intravenous Iron Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous Iron Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous Iron Drugs Market Share Forecast by Type (2018-2023)
12.4 Intravenous Iron Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous Iron Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous Iron Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intravenous Iron Drugs Picture
Table Product Specifications of Intravenous Iron Drugs
Figure Global Sales Market Share of Intravenous Iron Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
